CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens. (5th June 2015)

• Record Type: Journal Article
• Authors: Tarzi, R M; Liu, J; Schneiter, S; Hill, N R; Page, T H; Cook, H T; Pusey, C D; Woollard, K J
• Is Part Of: Clinical and experimental immunology. Volume 181:Number 1(2015:Jul.)
• Page Start: 65
• Page End: 75
• Publication Date: 2015-06-05
• Subjects: anti-neutrophil cytoplasm antibody (ANCA) -- monocyte -- myeloperoxidase (MPO) -- proteinase 3 (PR3); Immunopathology -- Periodicals; 616.079
• DOI: 10.1111/cei.12625
• Languages: English
• ISSNs: 0009-9104

Abstract

Summary: Monocyte subsets with differing functional properties have been defined by their expression of CD14 and CD16. We investigated these subsets in anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) and determined their surface expression of ANCA autoantigens. Flow cytometry was performed on blood from 14 patients with active AAV, 46 patients with AAV in remission and 21 controls. The proportion of classical (CD14 high CD16 neg/low ), intermediate (CD14 high CD16 high ) and non-classical (CD14 low CD16 high ) monocytes and surface expression levels of CD14 and CD16 were determined, as well as surface expression of proteinase 3 (PR3) and myeloperoxidase (MPO) on monocyte subsets. There was no change in the proportion of monocytes in each subset in patients with AAV compared with healthy controls. The expression of CD14 on monocytes from patients with active AAV was increased, compared with patients in remission and healthy controls ( P < 0·01). Patients with PR3-ANCA disease in remission also had increased monocyte expression of CD14 compared with controls ( P < 0·01); however, levels in patients with MPO-ANCA disease in remission were lower than active MPO-ANCA patients, and not significantly different from controls. There was a correlation between CD14 and both PR3 and MPO expression on classical monocytes in AAV patients ( r = 0·79, P < 0·0001 and r = 0·42, P < 0·005, respectively). In conclusion, there was an increase in monocyte CD14 expression in active AAV and PR3-ANCA disease in remission. The correlation of CD14 expression with ANCA autoantigen expression in AAV may reflect cell activation, and warrants further investigation into the potential for increased CD14 expression to trigger disease induction or relapse.